**Core Concept**
The question is testing the student's knowledge of the hepatotoxic effects of certain inhalational anesthetics. This concept is crucial in understanding the potential risks associated with the use of these agents in clinical practice.

**Why the Correct Answer is Right**
The correct answer is Sevoflurane. Sevoflururane is known to be metabolized by liver enzymes, specifically cytochrome P450 2E1, to produce compound A, a potential nephrotoxin. However, it also undergoes minor hepatic metabolism, which can lead to liver toxicity, especially in patients with pre-existing liver disease.

**Why Each Wrong Option is Incorrect**
**Option A:** Isoflurane - Isoflurane is not known to cause significant hepatotoxicity and is considered a safe agent in terms of liver effects.
**Option B:** Desflurane - Desflurane is also not associated with hepatotoxicity and is often used as a substitute for Sevoflurane in patients at risk.
**Option C:** Halothane - While Halothane is known to cause hepatitis, this is primarily due to a rare but severe idiosyncratic reaction, and not through direct hepatotoxicity.

**Clinical Pearl / High-Yield Fact**
When using Sevoflurane, especially in patients with pre-existing liver disease, consider using alternative agents and monitor liver function closely to minimize the risk of hepatotoxicity.

**Correct Answer: C. Halothane.**